Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells

The ELISpot assay is used for the detection of T cell responses in clinical trials and vaccine evaluations. Standardization and reproducibility are necessary to compare the results worldwide, inter- and intra-assay variability being critical factors. To assure operator safety as well as high-quality experiment performance, the ELISpot assay was implemented on an automated liquid handling platform, a Tecan Freedom EVO. After validation of the liquid handling, automated loading of plates with cells and reagents was investigated. With step by step implementation of the manual procedure and liquid dispensing optimization on the robot platform, a fully automated ELISpot assay was accomplished with plates remaining in the system from the plate blocking step to spot development. The mean delta difference amounted to a maximum of 6%, and the mean dispersion was smaller than in the manual assay. Taken together, we achieved with this system not only a lower personnel attendance but also higher throughput and a more precise and parallelized analysis. This platform has the potential to guarantee validated, safe, fast, reproducible and cost-efficient immunological and toxicological assays in the future.

[1]  O Ouchterlony,et al.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[2]  Sylvia Janetzki,et al.  Response determination criteria for ELISPOT: toward a standard that can be applied across laboratories. , 2012, Methods in molecular biology.

[3]  Austin G Smith,et al.  Automated Large-Scale Culture and Medium-Throughput Chemical Screen for Modulators of Proliferation and Viability of Human Induced Pluripotent Stem Cell–Derived Neuroepithelial-like Stem Cells , 2013, Journal of biomolecular screening.

[4]  M. Dittrich,et al.  Statistical analysis of ELISPOT assays. , 2012, Methods in molecular biology.

[6]  D. Ankerst,et al.  Impact of cryopreservation on tetramer, cytokine flow cytometry, and ELISPOT , 2005, BMC Immunology.

[7]  Sabine Neuss,et al.  Standardization of Automated Cell-Based Protocols for Toxicity Testing of Biomaterials , 2011, Journal of biomolecular screening.

[8]  Sylvia Janetzki,et al.  Automation of the Elispot Technique: Past, Present, and Future , 2004 .

[9]  Heiko Zimmermann,et al.  An Automated HIV-1 Env-Pseudotyped Virus Production for Global HIV Vaccine Trials , 2012, PloS one.

[10]  O Ouchterlony,et al.  Reverse ELISPOT assay for clonal analysis of cytokine production. I. Enumeration of gamma-interferon-secreting cells. , 1988, Journal of immunological methods.

[11]  S Janetzki,et al.  Evaluation of Elispot assays: influence of method and operator on variability of results. , 2004, Journal of immunological methods.

[12]  Sylvia Janetzki,et al.  Measurement of cytokine release at the single cell level using the ELISPOT assay. , 2006, Methods.

[13]  Holden T Maecker,et al.  Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides , 2008, BMC Immunology.

[14]  Jon Wakefield,et al.  The automated counting of spots for the ELISpot assay. , 2006, Journal of immunological methods.

[15]  E. Bathoorn,et al.  Diagnostic Potential of an Enzyme-Linked Immunospot Assay in Tuberculous Pericarditis , 2011, Clinical and Vaccine Immunology.

[16]  R. Koup,et al.  Automating Procedures for Processing, Cryopreservation, Storage, and Manipulation of Human Peripheral Blood Mononuclear Cells , 2004 .

[17]  L. Sarkozi,et al.  The effects of total laboratory automation on the management of a clinical chemistry laboratory. Retrospective analysis of 36 years. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[18]  M. Disis,et al.  ELISpot for measuring human immune responses to vaccines , 2011, Expert review of vaccines.

[19]  Y. Obase,et al.  Rapid diagnosis of tuberculous pericarditis by ELISPOT assay , 2010, Scandinavian journal of infectious diseases.

[20]  H. von Briesen,et al.  Temperature fluctuations during deep temperature cryopreservation reduce PBMC recovery, viability and T-cell function. , 2013, Cryobiology.

[21]  V. Maino,et al.  VACUTAINER® CPT™ and Ficoll density gradient separation perform equivalently in maintaining the quality and function of PBMC from HIV seropositive blood samples , 2006, BMC Immunology.

[22]  A. Mirazimi,et al.  Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine. , 2012, Vaccine.

[23]  Sergey S Zadorozhny,et al.  Mathematical algorithms for automatic search, recognition, and detection of spots in ELISPOT assay. , 2012, Methods in molecular biology.

[24]  J. C. Schulz,et al.  Towards a xeno-free and fully chemically defined cryopreservation medium for maintaining viability, recovery, and antigen-specific functionality of PBMC during long-term storage. , 2012, Journal of immunological methods.

[25]  M. John,et al.  Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses. , 2009, Journal of immunological methods.

[26]  Hao Jiang,et al.  A User-Friendly Robotic Sample Preparation Program for Fully Automated Biological Sample Pipetting and Dilution to Benefit the Regulated Bioanalysis , 2012, Journal of laboratory automation.

[27]  C. Czerkinsky,et al.  ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. , 1989, AIDS research and human retroviruses.

[28]  Sylvia Janetzki,et al.  Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) , 2007, Cancer Immunology, Immunotherapy.

[29]  Sylvia Janetzki,et al.  Standardization and validation issues of the ELISPOT assay. , 2005, Methods in molecular biology.

[30]  Ursula Graf-Hausner,et al.  Development of a Novel Automated Cell Isolation, Expansion, and Characterization Platform , 2011, Journal of laboratory automation.

[31]  P. Romero,et al.  HLA‐A*0201 restricted CD8+ T‐lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN‐γ ELISPOT , 2000, Parasite immunology.

[32]  Takanori Takebe,et al.  Establishment of automated culture system for murine induced pluripotent stem cells , 2012, BMC Biotechnology.

[33]  Douglas Densmore,et al.  Automated assembly of standard biological parts. , 2011, Methods in enzymology.